Docencia

How safe is TDF/FTC as PrEP? A systematic review and meta-analysis of the risk of adverse events in 13 randomised trials of PrEP (01-03-2019)

Dra. Carmen Hidalgo Tenorio. FEA de la UGC de Enfermedades Infecciosas. Hospital Universitario Virgen de las Nieves, Granada

A randomized, placebo-controlled trial of the quadrivalent HPV vaccine in HIV-infected adults age 27 years or older: AIDS Clinical Trials Group protocol A5298 (15-02-2019)

Dra. María Saumoy Unidad de VIH y ETS. Servicio de Enfermedades Infecciosas. Hospital Universitario Bellvitge, Barcelona.

Mechanisms that contribute to a profound reduction of the HIV-1 reservoir after allogeneic stem cell transplant (01-02-2019)

Dra. Luz Martín Carbonero. Medicina Interna Hospital. Universitario La Paz, Madrid

Dolutegravir mas lamivudina frente a dolutegravir mas tenofovir disoproxilo fumarato y emtricitabina en adultos con infección por VIH no tratados previamente (01-02-2019)

Dr. Pablo Ryan. Servicio de Medicina Interna. Hospital Universitario Infanta Leonor, Madrid.

Cardiovascular disease and use of contemporary protease inhibitors: the D:A:D international prospective multicohort study (15-01-2019)

Dr. Enrique Bernal. Unidad de Enfermedades Infecciosas. Hospital General Universitario Reina Sofía

Mechanisms that contribute to a profound reduction of the HIV-1 reservoir after allogeneic stem cell transplant (02-01-2019)

Dra. Luz Martín Carbonero. Medicina Interna. Hospital Universitario La Paz, Madrid

Hepatocellular carcinoma after sustained virological response with interferon-free regimens in HIV/Hepatitis C virus-coinfected patients (14-12-2018)

Dr. Juan Luis Gómez Sirvent. Sección de infecciones. Hospital Universitario de Canarias, Santa Cruz de Tenerife

Birth outcomes for pregnant women with HIV using Tenofovir-Emtricitabine (03-12-2018)

Dra. Carmen Hidalgo. FEA de la Unidad de Gestión Clínica de Enfermedades Infecciosas. Hospital Universitario Virgen de las Nieves, Granada

A randomized clinical trial of infrared coagulation ablation versus active monitoring of intra-anal high-grade dysplasia in adults with human immunodeficiency virus infection: an aids malignancy consortium trial (15-11-2018)

Dra. María Saumoy. Unidad de VIH y ETS. Servicio de Enfermedades Infecciosas. Hospital Universitario de Bellvitge, Barcelona

Benefits and harms of lung cancer screening in HIV-infected individuals with CD4+ cell count at least 500 cells/ml (31-10-2018)

Dr.Pablo Ryan. Servicio de Medicina Interna. Hospital Universitario Infanta Leonor. Madrid

Viral suppression and HIV transmission in serodiscordant male couples: an international, prospective, observational, cohort study (15-10-2018)

Dr. Enrique Bernal. Unidad de Enfermedades Infecciosas. Hospital General Universitario Reina Sofía.

Phase 3 study of Ibalizumab for multidrug-resistant HIV-1 (01-10-2018)

Dra. Luz Martín Carbonero. Medicina Interna. Hospital Universitario La Paz, Madrid.

Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults HIV-1 (DRIVE-FORWARD): 48- week results of a randomised, double-blind, phase 3, non inferiority trial (15-06-2018)

Dr. Julián Olalla Sierra. Especialista en Medicina Interna Hospital Costa del Sol, Marbella

Post-exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomised substudy of the ANRS IPERGAY trial (01-06-2018)

Dra. Marta Montero Alonso. Unidad de Enfermedades Infecciosas. Hospital Universitario y Politécnico la Fe, Valencia.

Recent Abacavir Use Increases Risk of Type 1 and Type 2 Myocardial Infarctions Among Adults With HIV (14-05-2018)

Dra. Matilde Sánchez Conde. Infectious Diseases Unit. Hospital Ramón y Cajal, Madrid

Tenofovir alafenamide plus emtricitabine versus abacavir plus lamivudine for treatment of virologically suppressed HIV-1-infected adults: a randomised, double-blind, active-controlled, non-inferiority phase 3 trial (05-05-2018)

Dr. Arkaitz Imaz. Servicio de Enfermedades Infecciosas Hospital Universitario de Bellvitge, Barcelona

Which HIV-infected adults with high CD4 T-cell counts benefit most from immediate initiation of antiretroviral therapy? A post-hoc subgroup analysis of the START trial (16-04-2018)

Dr. Esteban Martínez. Infectious Diseases Unit. Hospital Clínic, University of Barcelona

Disparities in the Quality of Cardiovascular Care Between HIV-Infected Versus HIVUninfected Adults in the United States: A Cross-Sectional Study (02-04-2018)

Dra. Ana Mariño. Unidad de VIH. Hospital Arquitecto Marcide-Novoa Santos, A Coruña.

Non Antiretrocial Polypharmacy and Adverse Health Outcomes Amon HIV. Infected and Uninfected Individuals (15-03-2018)

Dr. Julián Olalla Sierra. Especialista en Medicina Interna Hospital Costa del Sol, Marbella

Página 4 de 812345678

Accesos directos